Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers
Clinical trial NCT04114461 · COMPLETED
Trial details
- NCT number
- NCT04114461
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2019-12-04
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.